1. Home
  2. WABC vs MPLT Comparison

WABC vs MPLT Comparison

Compare WABC & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Westamerica Bancorporation

WABC

Westamerica Bancorporation

HOLD

Current Price

$59.09

Market Cap

1.5B

Sector

Finance

ML Signal

HOLD

Logo MapLight Therapeutics Inc.

MPLT

MapLight Therapeutics Inc.

HOLD

Current Price

$13.00

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WABC
MPLT
Founded
1972
2018
Country
United States
United States
Employees
627
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
1994
2025

Fundamental Metrics

Financial Performance
Metric
WABC
MPLT
Price
$59.09
$13.00
Analyst Decision
Hold
Strong Buy
Analyst Count
2
7
Target Price
$54.00
$32.67
AVG Volume (30 Days)
101.5K
571.1K
Earning Date
04-16-2026
05-28-2026
Dividend Yield
3.35%
N/A
EPS Growth
N/A
82.39
EPS
3.40
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.93
$9.10
52 Week High
$63.61
$40.43

Technical Indicators

Market Signals
Indicator
WABC
MPLT
Relative Strength Index (RSI) 47.88 44.43
Support Level $58.27 $10.67
Resistance Level $60.63 $20.20
Average True Range (ATR) 1.04 0.95
MACD 0.04 0.80
Stochastic Oscillator 75.28 89.76

Price Performance

Historical Comparison
WABC
MPLT

About WABC Westamerica Bancorporation

Westamerica Bancorp provides a full range of banking services to individual and commercial customers in Northern and Central California through its subsidiary bank. The Bank is a California-chartered commercial bank whose deposits are insured by the Federal Deposit Insurance Corporation (the FDIC) up to applicable limits. The principal communities served are located in Northern and Central California, from Mendocino, Lake and Nevada Counties in the north to Kern County in the south. The Company's strategic focus is on the banking needs of small businesses.

About MPLT MapLight Therapeutics Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

Share on Social Networks: